On CNBC’s “Halftime Report Final Trades,” on Monday, Amy Raskin, chief funding officer at Chevy Chase Trust, named Ascendis Pharma A/S (NASDAQ:ASND) as her final trade.
According to latest information, the U.S. Food & Drug Administration (FDA) on Nov. 25 prolonged the evaluate interval for Ascendis Pharma’s New Drug Application (NDA) for TransCon CNP (navepegritide) for kids with achondroplasia. The FDA stated the knowledge submitted on Nov. 5, associated to the put up-advertising and marketing requirement constituted a serious modification to the NDA. Accordingly, the FDA has prolonged the PDUFA goal motion date by three months to Feb. 28, 2026.
Shannon Saccocia, chief funding officer of NB Private Wealth, picked iShares US Consumer Discretionary ETF (NYSE:IYC), saying client discretionary is beginning to really feel a bit extra optimistic given the expansion expectations for the subsequent yr.
Don’t neglect to take a look at our premarket coverage here
Bryn Talkington, managing associate of Requisite Capital Management, named Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ:GPIQ) as her remaining commerce.
Supporting his view, Morgan Stanley analyst Terence Flynn maintained Vertex with an Overweight score and raised the worth goal from $516 to $564 on Friday.
Joseph M. Terranova, senior managing director for Virtus Investment Partners, picked Monolithic Power Systems Inc (NASDAQ:MPWR), a semi-gear identify, which has gained greater than 60% over the past yr.
On the earnings entrance, Monolithic Power, on Oct. 30, reported higher-than-anticipated third-quarter outcomes. The firm posted quarterly earnings of $4.73 per share, which beat the analyst consensus estimate of $4.64 per share. The firm reported quarterly gross sales of $737.176 million, which beat the analyst consensus estimate of $722.252 million.
Price Action:
- Ascendis Pharma rose 0.8% to shut at $207.12 on Monday.
- iShares US Consumer Discretionary ETF slipped 0.9% through the session.
- Monolithic Power shares gained 2.1% to shut at $983.58 on Monday.
- Goldman Sachs Nasdaq-100 Premium Income ETF slipped 0.2% through the session.
Check This Out:
Photo: Shutterstock